ACR, AAD, RDS, and AAO 2020 Joint Statement on Hydroxychloroquine Use with Respect to Retinal Toxicity

AbstractPrescribing clinicians and eye care specialists share responsibility for safely prescribing hydroxychloroquine (HCQ) and screening for the potential risk of retinopathy. Two relevant national societies, the American College of Rheumatology (ACR) and the American Academy of Ophthalmology (AAO), have independently offered management guidelines (1, 2), but this is the first joint statement to emphasize points of agreement that should be recognized by practitioners in all specialties.

Source: Arthritis and Rheumatology - February 9, 2021 Category: Rheumatology Authors: James T. Rosenbaum, Karen H. Costenbader, Julianna Desmarais, Ellen M. Ginzler, Nicole Fett, Susan M. Goodman, James R. O ’Dell, Gabriela Schmajuk, Victoria P. Werth, Ronald B. Melles, Michael F. Marmor Tags: SPECIAL ARTICLE Source Type: research